Lifecore Biomedical (LFCR) Misses Q2 EPS by 2c

Lifecore Biomedical (NASDAQ: LFCR) reported Q2 EPS of ($0.06), $0.02 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $36.44 million versus the consensus estimate of $35.36 million.

For earnings history and earnings-related data on Lifecore Biomedical (LFCR) click here.

You May Also Be Interested In

• Trump: Iran Will Pay For US Forces Killings Many Times Over
• Ed Miliband appointed UK's new Foreign Secretary
• Goldman Sachs on IREN Ltd. (IREN): 'We estimate that the newly announced contracts represent an additional ~$1 bn'